Inspira Technologies is making a bold step into the cancer diagnostics field. They've signed a preliminary deal to buy a company that specializes in liquid biopsy technology. This tech can detect cancer cells in blood samples using AI. The deal also includes a $15 million investment from an unnamed
PFAS chemicals, also known as "forever chemicals, " are found in many makeup products. These chemicals do not break down easily and can stay in the body and environment for a long time. A recent study found over 50 different PFAS chemicals in more than 1, 700 beauty products. This is a lot of potent
In a surprising turn of events, a significant number of everyday products have been pulled from shelves due to alarming contamination. The issue? Rodent and bird droppings found in the storage areas of a major distribution company. This isn't just about cleanliness; it's about potential health hazar
The stock market is ending the year on a down note. The Dow Jones Industrial Average is lower today. Investors are reacting to some big news from the FDA. This news has caused biotech stocks to drop. It's a reminder that the market can be unpredictable. The FDA's announcement has sent shockwaves th
The US Food and Drug Administration (FDA) has recently appointed Tracy Beth Høeg as the acting director of the Center for Drug Evaluation and Research (CDER). This move has sparked debate, as Høeg's background is primarily in sports medicine and epidemiology, with no apparent experience in drug deve
The U. S. Food and Drug Administration (FDA) has given the green light to a new drug called Nereus, designed to tackle motion sickness. This approval is a big deal because it's the first new treatment for this condition in over 40 years. The drug, also known as tradipitant, works by blocking a speci
Pfizer's stock took a hit recently, and it's all tied to a serious issue with one of their drugs. A patient in a long-term study for Hympavzi, a treatment for hemophilia, passed away due to severe complications. This news came out in December 2025, and it's got people talking. The patient had hemop
European markets are on a roll, hitting new highs. The Stoxx 600, DAX, and CAC 40 indexes have all seen significant gains. This year alone, the Stoxx 600 has climbed 14% higher. With just a week left, it's looking like it will be the third year in a row of growth. Investors are keeping a close eye
The FDA, once a beacon of scientific independence, is now caught in a political tug-of-war. The agency's new "Commissioner’s National Priority Voucher" program is a prime example of this shift. It promises faster reviews for companies that align with the administration's "national priorities. " But
The FDA is thinking about a big change to how warnings show up on supplement labels. Right now, every time a supplement claims to do something good for your health, like boost your immune system or help your heart, there's a bold warning. It says the FDA hasn't checked if the claim is true. But soon
